wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45932398-E1A8F15B-0677-4E10-B25B-9C08FD3F07F8
Q45932398-E1A8F15B-0677-4E10-B25B-9C08FD3F07F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45932398-E1A8F15B-0677-4E10-B25B-9C08FD3F07F8
Reply: Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib.
P2860
Q45932398-E1A8F15B-0677-4E10-B25B-9C08FD3F07F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45932398-E1A8F15B-0677-4E10-B25B-9C08FD3F07F8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
01a2fefb45d8c9a3cfcc225e42aec0d87af36e3e
P2860
Targeted therapy for advanced renal cell carcinoma